These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9418739

  • 1. Expression and upregulation of microtubule-associated protein 1B in cultured retinal pigment epithelial cells.
    Esser P, Grisanti S, Kociok N, Abts H, Hueber A, Unfried K, Heimann K, Weller M.
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2852-6. PubMed ID: 9418739
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of the RAS-GTPase activating protein (GAP)-binding protein (G3BP) in proliferating RPE cells.
    Kociok N, Esser P, Unfried K, Parker F, Schraermeyer U, Grisanti S, Toqué B, Heimann K.
    J Cell Biochem; 1999 Aug 01; 74(2):194-201. PubMed ID: 10404389
    [Abstract] [Full Text] [Related]

  • 3. Vitreous treatment of cultured human RPE cells results in differential expression of 10 new genes.
    Kociok N, Hueber A, Esser P, Schraermeyer U, Thumann G, Luther TT, Jordan J, Welsandt G, Kirchhof B.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2474-80. PubMed ID: 12091453
    [Abstract] [Full Text] [Related]

  • 4. Galectin-1 influences migration of retinal pigment epithelial cells.
    Alge CS, Priglinger SG, Kook D, Schmid H, Haritoglou C, Welge-Lussen U, Kampik A.
    Invest Ophthalmol Vis Sci; 2006 Jan 01; 47(1):415-26. PubMed ID: 16384992
    [Abstract] [Full Text] [Related]

  • 5. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
    Liu NP, Roberts WL, Hale LP, Levesque MC, Patel DD, Lu CL, Jaffe GJ.
    Invest Ophthalmol Vis Sci; 1997 Sep 01; 38(10):2027-37. PubMed ID: 9331266
    [Abstract] [Full Text] [Related]

  • 6. Expression of E-cadherin by human retinal pigment epithelium: delayed expression in vitro.
    Burke JM, Cao F, Irving PE, Skumatz CM.
    Invest Ophthalmol Vis Sci; 1999 Nov 01; 40(12):2963-70. PubMed ID: 10549658
    [Abstract] [Full Text] [Related]

  • 7. The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells.
    Abe T, Durlu YK, Tamai M.
    Exp Eye Res; 1996 Aug 01; 63(2):201-10. PubMed ID: 8983978
    [Abstract] [Full Text] [Related]

  • 8. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
    Casaroli-Marano RP, Pagan R, Vilaró S.
    Invest Ophthalmol Vis Sci; 1999 Aug 01; 40(9):2062-72. PubMed ID: 10440262
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
    Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M.
    Invest Ophthalmol Vis Sci; 1998 Jan 01; 39(1):164-70. PubMed ID: 9430558
    [Abstract] [Full Text] [Related]

  • 10. Vitreous modulation of gene expression in low-passage human retinal pigment epithelial cells.
    Ganti R, Hunt RC, Parapuram SK, Hunt DM.
    Invest Ophthalmol Vis Sci; 2007 Apr 01; 48(4):1853-63. PubMed ID: 17389521
    [Abstract] [Full Text] [Related]

  • 11. Altered gene expression of angiogenic factors induced by calcium-mediated dissociation of retinal pigment epithelial cells.
    Wang XF, Cui JZ, Prasad SS, Matsubara JA.
    Invest Ophthalmol Vis Sci; 2005 Apr 01; 46(4):1508-15. PubMed ID: 15790923
    [Abstract] [Full Text] [Related]

  • 12. Vitreous treatment of retinal pigment epithelial cells results in decreased expression of FGF-2.
    Hunt DM, Chen WH, Hunt RC.
    Invest Ophthalmol Vis Sci; 1998 Oct 01; 39(11):2111-20. PubMed ID: 9761290
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies.
    Kanuga N, Winton HL, Beauchéne L, Koman A, Zerbib A, Halford S, Couraud PO, Keegan D, Coffey P, Lund RD, Adamson P, Greenwood J.
    Invest Ophthalmol Vis Sci; 2002 Feb 01; 43(2):546-55. PubMed ID: 11818403
    [Abstract] [Full Text] [Related]

  • 17. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.
    Hangai M, Murata T, Miyawaki N, Spee C, Lim JI, He S, Hinton DR, Ryan SJ.
    Invest Ophthalmol Vis Sci; 2001 Jun 01; 42(7):1617-25. PubMed ID: 11381069
    [Abstract] [Full Text] [Related]

  • 18. Effect of quiescence on integrin alpha5beta1 expression in human retinal pigment epithelium.
    Proulx S, Guérin SL, Salesse C.
    Mol Vis; 2003 Oct 03; 9():473-81. PubMed ID: 14551535
    [Abstract] [Full Text] [Related]

  • 19. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L, Xu Y, Yu W, Li Y, Chu L, Dong J, Li X.
    Invest Ophthalmol Vis Sci; 2010 Jun 03; 51(6):3193-204. PubMed ID: 20071679
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
    Lashkari K, Rahimi N, Kazlauskas A.
    Invest Ophthalmol Vis Sci; 1999 Jan 03; 40(1):149-56. PubMed ID: 9888438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.